cITP

patient care perspectives

by Terry B. Gernsheimer, MD

Over the past decade, the understanding of immune thrombocytopenia (ITP) has expanded greatly through clinical studies and literature updates, whic......READ MORE

patient care perspectives

by Adam Cuker, MD, MS

Clinical studies have demonstrated that second-line treatment options for chronic immune thrombocytopenia (ITP), such as rituximab and the thrombop......READ MORE

patient care perspectives

by Howard A. Liebman, MD

The main goal of treatment in patients with chronic immune thrombocytopenia (ITP) is to minimize the bleeding risk, and this should be done by achi......READ MORE